Clinical TrialID 8024

Beta-alanine Supplementation and CrossFit Performance

NCT05772988

Exercise-Induced Lactic Acidemia

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
8024
Evidence Id
8024
Core Evidence Id
8024
Source Clinical Trial Id
8018
Herb2 Clinical Trial Id
HBCT008018
Nct Id
NCT05772988
Title
Beta-alanine Supplementation and CrossFit Performance
Status
Completed
Phase
Study Result
No
Study Condition
Exercise-Induced Lactic Acidemia
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Intervention
DIETARY_SUPPLEMENT: Beta-alanine|DIETARY_SUPPLEMENT: Maltodextrin
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Triple
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
12
Outcome Measure
Change from baseline in time to perform a "Fran" CrossFit workout, This involves alternating sets of dumbbell thrusters and pull-uips, Baseline, 3 weeks
Sponsor Collaborator
University of Saskatchewan
Funded By
OTHER
Location
University of Saskatchewan, Saskatoon, Saskatchewan, S7N5B2, Canada
Other Id
2022_23_02
Start Date
2023-03-15
Primary Completion Date
2023-08-31
Completion Date
2023-08-31
First Posted
2023-03-17
Results First Posted
Last Update Posted
2024-05-29
Study Document
Study Url
https://clinicaltrials.gov/study/NCT05772988
Title Cn
Title En
Beta-alanine Supplementation and CrossFit Performance
Bilingual Status
semi_complete